Stock Events

Stock Events

Abbvie 

$297.32
33574
+$10.42+3.63% 01:27 Today

Statistics

Day High
297.45
Day Low
295.17
52W High
299
52W Low
200.53
Volume
4,794
Avg. Volume
-
Mkt Cap
525.4B
P/E Ratio
-
Dividend Yield
2.54%
Dividend
7.54

Upcoming

Dividends

2.54%Dividend Yield
Nov 2026
$1.73
Aug 2026
$1.73
May 2026
$1.73
Feb 2026
$1.73
Nov 2025
$1.64
10Y Growth
11.89%
5Y Growth
6.1%
3Y Growth
5.3%
1Y Growth
5.56%

Earnings

Feb 3Expected
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Next
1.77
2.47
3.18
3.89
Expected EPS
3.888822
Actual EPS
N/A

Financials

6.91%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
61.16BRevenue
4.23BNet Income

Analyst Ratings

$306.47Average Price Target
The highest estimate is ⁦346.00⁩.
From 19 ratings within the last 6 months. This is not an investment recommendation.
Buy
84%
Hold
16%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ABBV.BOATS. It's not an investment recommendation.
Realty Income
10001
O
Microsoft
8506
MSFT
Apple
8407
AAPL
Coca-Cola
7316
KO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson competes with AbbVie in the pharmaceutical sector, particularly in immunology and oncology.
Pfizer
PFE
Mkt Cap173.95B
Pfizer competes across several therapeutic areas including immunology and oncology, similar to AbbVie's portfolio.
Merck
MRK
Mkt Cap368.89B
Merck is a key competitor in the pharmaceutical industry, especially in the oncology market where both companies have significant investments.
GSK
GSK
Mkt Cap99.19B
GlaxoSmithKline competes with AbbVie in the pharmaceutical and healthcare sector, with overlapping interests in immunology.
Novartis
NVS
Mkt Cap303.67B
Novartis competes with AbbVie in multiple areas including immunology and neuroscience.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol Myers Squibb competes in the biopharmaceutical sector, particularly in oncology and cardiovascular diseases, areas where AbbVie is also active.
AMGEN
AMGN
Mkt Cap251.94B
Amgen competes with AbbVie in the biotech sector, particularly in treatments for inflammatory diseases.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG competes with AbbVie in the oncology and immunology sectors, with a strong focus on biopharmaceuticals.
Sanofi
SNY
Mkt Cap106.24B
Sanofi competes with AbbVie in areas such as immunology, with both companies developing treatments for various autoimmune diseases.
Astrazeneca
AZN
Mkt Cap289.48B
AstraZeneca competes with AbbVie, particularly in the oncology sector, where both companies are seeking to expand their portfolios.

About

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Show More
CEO
ISIN
US00287Y1091

Listings

XNYS
US
ABBV
F
DE
4AB.F
STU
DE
4AB.STU
BK
TH
ABBV19.BK

0 Comments

Share your thoughts

FAQs

What is Abbvie stock price today?▼
The current price of ABBV.BOATS is $297.32 USD — it has increased by +3.63% in the past 24 hours. Watch Abbvie stock price performance more closely on the chart.
What is Abbvie stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Abbvie stocks are traded under the ticker ABBV.BOATS.
What is Abbvie market cap?▼
Today Abbvie has the market capitalization of 525.4B
When is the next Abbvie earnings date?▼
Abbvie is going to release the next earnings report on February 3, 2027.
What were Abbvie earnings last quarter?▼
ABBV.BOATS earnings for the last quarter are 3.82 USD per share, whereas the estimation was 3.73 USD resulting in a +2.51% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Abbvie revenue for the last year?▼
Abbvie revenue for the last year amounts to 61.16B USD.
What is Abbvie net income for the last year?▼
ABBV.BOATS net income for the last year is 4.23B USD.
Does Abbvie pay dividends?▼
Yes, ABBV.BOATS dividends are paid quarterly. The last dividend per share was 1.73 . As of today, Dividend Yield (FWD)% is 2.54%.
In which sector is Abbvie located?▼
Abbvie operates in the Other sector.
When did Abbvie complete a stock split?▼
Abbvie has not had any recent stock splits.